33
/it/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
November 1, 2025
2135666
178559
2
Create a timeline
Public Timelines
For educational institutions For teachers For students Cabinet
For educational institutions For teachers For students Open cabinet
FAQ Ricevere il Premium
Create a timeline
Public timelines
FAQ
About & FeedbackAccordoPrivatezzaFAQ
Support 24/7  
CabinetGet premium
Donate

8 giug 2017 anni - FDA requested that Endo Pharmaceuticals remove its opioid pain medication, reformulated Opana ER (oxymorphone hydrochloride), from the market based on its concern that the benefits of the drug may no longer outweigh its risks.

Aggiunto al nastro di tempo:

Opioids and the FDA

ByAnastasia
13 nov 2018
0
0
523

Data:

8 giug 2017 anni
Adesso
~ 8 years and 4 months ago
About & FeedbackAccordoPrivatezzaFAQ
Support 24/7  
CabinetGet premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL